Learn To Invest
Stocks Special Reports LICs Credit Funds ETFs Tools SMSFs
Video Archive Article Archive
News Stocks Special Reports Funds ETFs Features SMSFs Learn

Company News Summary

Australian Pharmaceutical Industries Reports HY 2021 Results

22 Apr 2021  |  09:10:00  |  Associate analysts  |  Increase  |  Decrease  |  

Original announcement: API HY21 Results ASX Release

Australian Pharmaceutical Industries announced for the half year ending 28 February 2021, underlying EBIT was $32.0m, down 26.5% on the pcp, and underlying NPAT, was $17.7m, down 30.3% on the pcp all stemming from the effect of COVID over the period. The Total revenue was $2.0bn, down 2.6% on pcp. It noted of an interim dividend of 1.5c, representing a payout of 47% of NPAT. The Company advised on further improvement in working capital management with cash conversion days 17.8, down 4.2 days on pcp.

Please click here for full details

See more ASX300 News Announcements